Component
Trivalent chromium / Cr(III)
Trivalent chromium / Cr(III). Species, exposure and limitations are retained in each linked claim.
14 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
The preparation’s ability to enhance insulin-receptor tyrosine-kinase activity depended on its chromium content.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/9109644.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "23e955cef071c135f3935f440f4e333d49f494f004ceb22574df717c86bb7283", "start_char": 0, "end_char": 939, "text_sha256": "23e955cef071c135f3935f440f4e333d49f494f004ceb22574df717c86bb7283"}
- experimental_model
- Isolated rat insulin receptor and adipocyte membrane kinase assays
- exposure
- Insulin activation with added low-molecular-weight chromium-binding material
- limitations
- Assay activity is distinct from proof of an endogenous human cofactor. The peptide preparation and its cellular origin remain disputed; chromium is not shown to be an obligatory catalytic metal of INSR.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Rat receptor; isolated chromium oligopeptide preparation
- plain_language
- Removing the preparation’s metal content reduced its assay effect; that does not establish dietary chromium deficiency in humans.
- primary_references
- [chromium-p9109644] Chromium oligopeptide activates insulin receptor tyrosine kinase activity. (1997). https://pubmed.ncbi.nlm.nih.gov/9109644/ DOI: 10.1021/bi963154t
- tissue_or_cell_type
- Purified receptor and membrane fragments
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 276–287
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isolated rat insulin receptor and adipocyte membrane kinase assays · source_derived_draft · unverified_draft
### chromium-chromodulin-metal-dependence The preparation’s ability to enhance insulin-receptor tyrosine-kinase activity depended on its chromium content. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: Removing the preparation’s metal content reduced its assay effect; that does not establish dietary chromium deficiency in humans. organism: Rat receptor; isolated chromium oligopeptide preparation tissue_or_cell_type: Purified receptor and membrane fragments experimental_model: Isolated rat insulin receptor and adipocyte membrane kinase assays limitations: Assay activity is distinct from proof of an endogenous human cofactor. The peptide preparation and its cellular origin remain disputed; chromium is not shown to be an obligatory catalytic metal of INSR. exposure: Insulin activation with added low-molecular-weight chromium-binding material evidence_span: {"source_cache": "artifacts/chromium-research/9109644.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "23e955cef071c135f3935f440f4e333d49f494f004ceb22574df717c86bb7283", "start_char": 0, "end_char": 939, "text_sha256": "23e955cef071c135f3935f440f4e333d49f494f004ceb22574df717c86bb7283"} [chromium-p9109644] Chromium oligopeptide activates insulin receptor tyrosine kinase activity. (1997). https://pubmed.ncbi.nlm.nih.gov/9109644/ DOI: 10.1021/bi963154t
Complete structured claim and evidenceThe characterized pre-reacted Cr(III)-cysteine, -glutathione and -ascorbate preparations did not measurably bind DNA or form the proposed ternary adducts under the tested conditions.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/36662348.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "500f334d72ca34561016a11f0c3bf866998ee364085855e54a2f29025bc916a8", "start_char": 0, "end_char": 1155, "text_sha256": "500f334d72ca34561016a11f0c3bf866998ee364085855e54a2f29025bc916a8"}
- experimental_model
- Characterization of pre-reacted chromium-ligand preparations and DNA-binding assays
- exposure
- Pre-reacted chromium cysteinate, chromium glutathione and chromium ascorbate preparations
- limitations
- These preparation-specific results challenge earlier assignments but do not show that Cr(VI) is harmless or directly reproduce every reductive chromate-DNA reaction.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Cell-free chemistry
- plain_language
- Pre-forming a metal complex can give a different result from reducing chromate in the presence of DNA; the claimed lesion identity needs checking.
- primary_references
- [chromium-p36662348] Examining the Potential Formation of Ternary DNA Complexes with Chromium‑Cysteine, Chromium-Ascorbate, and Chromium-Glutathione and Implications for Their Carcinogenicity. (2023). https://pubmed.ncbi.nlm.nih.gov/36662348/ DOI: 10.1007/s12011-023-03573-8
- tissue_or_cell_type
- Defined chromium complexes and DNA
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 1186–1197
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Characterization of pre-reacted chromium-ligand preparations and DNA-binding assays · source_derived_draft · unverified_draft
### chromium-prereacted-dna-binding-null The characterized pre-reacted Cr(III)-cysteine, -glutathione and -ascorbate preparations did not measurably bind DNA or form the proposed ternary adducts under the tested conditions. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: Pre-forming a metal complex can give a different result from reducing chromate in the presence of DNA; the claimed lesion identity needs checking. organism: Cell-free chemistry tissue_or_cell_type: Defined chromium complexes and DNA experimental_model: Characterization of pre-reacted chromium-ligand preparations and DNA-binding assays limitations: These preparation-specific results challenge earlier assignments but do not show that Cr(VI) is harmless or directly reproduce every reductive chromate-DNA reaction. exposure: Pre-reacted chromium cysteinate, chromium glutathione and chromium ascorbate preparations evidence_span: {"source_cache": "artifacts/chromium-research/36662348.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "500f334d72ca34561016a11f0c3bf866998ee364085855e54a2f29025bc916a8", "start_char": 0, "end_char": 1155, "text_sha256": "500f334d72ca34561016a11f0c3bf866998ee364085855e54a2f29025bc916a8"} [chromium-p36662348] Examining the Potential Formation of Ternary DNA Complexes with Chromium‑Cysteine, Chromium-Ascorbate, and Chromium-Glutathione and Implications for Their Carcinogenicity. (2023). https://pubmed.ncbi.nlm.nih.gov/36662348/ DOI: 10.1007/s12011-023-03573-8
Complete structured claim and evidenceCr(III) uptake and vascular transfer were nonsaturable across 0.2–20 µmol/L in the perfused rat intestine; the authors interpreted the behavior as passive diffusion.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/2778539.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1c3f4249245a1ed57e89179e1f751a537e52fe566de25a9859833895553d2e0e", "start_char": 0, "end_char": 1379, "text_sha256": "1c3f4249245a1ed57e89179e1f751a537e52fe566de25a9859833895553d2e0e"}
- experimental_model
- Vascularly perfused small-intestine preparation
- exposure
- Inorganic Cr(III) 0.2–20 µmol/L; chromium-adequate diet before preparation
- limitations
- Nonsaturability supports passive uptake under this preparation; it does not identify a human transporter or cover all supplement complexes.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Rat
- plain_language
- This rat preparation did not show a saturable uptake system over the tested range.
- primary_references
- [chromium-p2778539] Absorption of inorganic, trivalent chromium from the vascularly perfused rat small intestine. (1989). https://pubmed.ncbi.nlm.nih.gov/2778539/ DOI: 10.1093/jn/119.8.1138
- tissue_or_cell_type
- Intestinal lumen, wall and vascular perfusate
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 94–105
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Vascularly perfused small-intestine preparation · source_derived_draft · unverified_draft
### chromium-rat-intestinal-uptake Cr(III) uptake and vascular transfer were nonsaturable across 0.2–20 µmol/L in the perfused rat intestine; the authors interpreted the behavior as passive diffusion. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: This rat preparation did not show a saturable uptake system over the tested range. organism: Rat tissue_or_cell_type: Intestinal lumen, wall and vascular perfusate experimental_model: Vascularly perfused small-intestine preparation limitations: Nonsaturability supports passive uptake under this preparation; it does not identify a human transporter or cover all supplement complexes. exposure: Inorganic Cr(III) 0.2–20 µmol/L; chromium-adequate diet before preparation evidence_span: {"source_cache": "artifacts/chromium-research/2778539.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1c3f4249245a1ed57e89179e1f751a537e52fe566de25a9859833895553d2e0e", "start_char": 0, "end_char": 1379, "text_sha256": "1c3f4249245a1ed57e89179e1f751a537e52fe566de25a9859833895553d2e0e"} [chromium-p2778539] Absorption of inorganic, trivalent chromium from the vascularly perfused rat small intestine. (1989). https://pubmed.ncbi.nlm.nih.gov/2778539/ DOI: 10.1093/jn/119.8.1138
Complete structured claim and evidence
What acts on it
The bovine-liver low-molecular-weight isolate contained approximately four Cr(III) ions per peptide, with spectra consistent with carboxylate-supported metal assemblies; one tetranuclear versus two dinuclear assemblies was unresolved.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/9056266.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "36be61aa6271d3491a4432d31d5ea6524a059fcc1f1ba1e0acac5f175f711a06", "start_char": 0, "end_char": 791, "text_sha256": "36be61aa6271d3491a4432d31d5ea6524a059fcc1f1ba1e0acac5f175f711a06"}
- experimental_model
- Isolation and spectroscopy of a bovine-liver chromium-containing peptide fraction
- exposure
- Spectroscopic characterization of an isolate with approximately four Cr(III) ions per peptide
- limitations
- The paper interpreted the isolate as naturally occurring; later work questioned whether similar low-molecular-weight species arise during extraction. Exact nuclearity was not resolved by this study.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Bovine liver isolate
- plain_language
- Researchers isolated a chromium-binding peptide fraction, but its structure and origin inside living cells were not fully settled.
- primary_references
- [chromium-p9056266] Isolation and characterization of a biologically active chromium oligopeptide from bovine liver. (1997). https://pubmed.ncbi.nlm.nih.gov/9056266/ DOI: 10.1006/abbi.1997.9878
- tissue_or_cell_type
- Purified fraction outside intact cells
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 224–235
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isolation and spectroscopy of a bovine-liver chromium-containing peptide fraction · source_derived_draft · unverified_draft
### chromium-chromodulin-isolate The bovine-liver low-molecular-weight isolate contained approximately four Cr(III) ions per peptide, with spectra consistent with carboxylate-supported metal assemblies; one tetranuclear versus two dinuclear assemblies was unresolved. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: Researchers isolated a chromium-binding peptide fraction, but its structure and origin inside living cells were not fully settled. organism: Bovine liver isolate tissue_or_cell_type: Purified fraction outside intact cells experimental_model: Isolation and spectroscopy of a bovine-liver chromium-containing peptide fraction limitations: The paper interpreted the isolate as naturally occurring; later work questioned whether similar low-molecular-weight species arise during extraction. Exact nuclearity was not resolved by this study. exposure: Spectroscopic characterization of an isolate with approximately four Cr(III) ions per peptide evidence_span: {"source_cache": "artifacts/chromium-research/9056266.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "36be61aa6271d3491a4432d31d5ea6524a059fcc1f1ba1e0acac5f175f711a06", "start_char": 0, "end_char": 791, "text_sha256": "36be61aa6271d3491a4432d31d5ea6524a059fcc1f1ba1e0acac5f175f711a06"} [chromium-p9056266] Isolation and characterization of a biologically active chromium oligopeptide from bovine liver. (1997). https://pubmed.ncbi.nlm.nih.gov/9056266/ DOI: 10.1006/abbi.1997.9878
Complete structured claim and evidenceCr(III)-transferrin crystals contained a chromium-loaded closed C-terminal lobe and an open empty N-terminal lobe; two tyrosines, histidine, aspartate and chelating malonate coordinated the metal.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/32650146.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "826e2d7f86ec2016d526ca8a8858db0249f4797aad842189d7f0359b6f375f85", "start_char": 0, "end_char": 1004, "text_sha256": "826e2d7f86ec2016d526ca8a8858db0249f4797aad842189d7f0359b6f375f85"}
- experimental_model
- X-ray crystallography of chromium-loaded transferrin
- exposure
- Cr(III)-transferrin crystallized with malonate as the synergistic anion
- limitations
- Crystal ligands and occupancy depend on preparation; malonate is not evidence that every circulating complex has the same coordination environment.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Human serum transferrin
- plain_language
- The iron-carrier protein can bind chromium in a structurally characterized pocket.
- primary_references
- [chromium-p32650146] X-ray structure of chromium(III)-containing transferrin: First structure of a physiological Cr(III)-binding protein. (2020). https://pubmed.ncbi.nlm.nih.gov/32650146/ DOI: 10.1016/j.jinorgbio.2020.111101
- tissue_or_cell_type
- Protein crystals
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 146–157
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · X-ray crystallography of chromium-loaded transferrin · source_derived_draft · unverified_draft
### chromium-transferrin-crystal Cr(III)-transferrin crystals contained a chromium-loaded closed C-terminal lobe and an open empty N-terminal lobe; two tyrosines, histidine, aspartate and chelating malonate coordinated the metal. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: The iron-carrier protein can bind chromium in a structurally characterized pocket. organism: Human serum transferrin tissue_or_cell_type: Protein crystals experimental_model: X-ray crystallography of chromium-loaded transferrin limitations: Crystal ligands and occupancy depend on preparation; malonate is not evidence that every circulating complex has the same coordination environment. exposure: Cr(III)-transferrin crystallized with malonate as the synergistic anion evidence_span: {"source_cache": "artifacts/chromium-research/32650146.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "826e2d7f86ec2016d526ca8a8858db0249f4797aad842189d7f0359b6f375f85", "start_char": 0, "end_char": 1004, "text_sha256": "826e2d7f86ec2016d526ca8a8858db0249f4797aad842189d7f0359b6f375f85"} [chromium-p32650146] X-ray structure of chromium(III)-containing transferrin: First structure of a physiological Cr(III)-binding protein. (2020). https://pubmed.ncbi.nlm.nih.gov/32650146/ DOI: 10.1016/j.jinorgbio.2020.111101
Complete structured claim and evidence
Where it participates (unsigned role)
Acidic pH promoted rapid Cr(III) release from the weak transferrin site; release from the tighter site was slower and depended on the chelating environment.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/31669693.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "bdb962ff7838d36dfbc2cd2df4eed4e07c81ebd824c6e95096c5d7069ec32835", "start_char": 0, "end_char": 1635, "text_sha256": "bdb962ff7838d36dfbc2cd2df4eed4e07c81ebd824c6e95096c5d7069ec32835"}
- experimental_model
- Purified human transferrin release kinetics and soluble receptor interaction
- exposure
- pH 4.5 and 5.5; weak/tight binding sites; biological chelators and soluble transferrin receptor
- limitations
- The study establishes release kinetics, not the entire in-vivo pathway. The molecular route from the endosomal lumen to cytosol remains unresolved.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Human proteins in vitro
- plain_language
- Acidification helps release chromium from its carrier, with different behavior at the two sites.
- primary_references
- [chromium-p31669693] Release of trivalent chromium from serum transferrin is sufficiently rapid to be physiologically relevant. (2020). https://pubmed.ncbi.nlm.nih.gov/31669693/ DOI: 10.1016/j.jinorgbio.2019.110901
- tissue_or_cell_type
- Endosome-mimicking solution
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 159–170
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human transferrin release kinetics and soluble receptor interaction · source_derived_draft · unverified_draft
### chromium-acidic-release Acidic pH promoted rapid Cr(III) release from the weak transferrin site; release from the tighter site was slower and depended on the chelating environment. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: Acidification helps release chromium from its carrier, with different behavior at the two sites. organism: Human proteins in vitro tissue_or_cell_type: Endosome-mimicking solution experimental_model: Purified human transferrin release kinetics and soluble receptor interaction limitations: The study establishes release kinetics, not the entire in-vivo pathway. The molecular route from the endosomal lumen to cytosol remains unresolved. exposure: pH 4.5 and 5.5; weak/tight binding sites; biological chelators and soluble transferrin receptor evidence_span: {"source_cache": "artifacts/chromium-research/31669693.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "bdb962ff7838d36dfbc2cd2df4eed4e07c81ebd824c6e95096c5d7069ec32835", "start_char": 0, "end_char": 1635, "text_sha256": "bdb962ff7838d36dfbc2cd2df4eed4e07c81ebd824c6e95096c5d7069ec32835"} [chromium-p31669693] Release of trivalent chromium from serum transferrin is sufficiently rapid to be physiologically relevant. (2020). https://pubmed.ncbi.nlm.nih.gov/31669693/ DOI: 10.1016/j.jinorgbio.2019.110901
Complete structured claim and evidenceMost Cr(III) formed in Cr(VI)-treated cells was associated with high-molecular-mass ligands; cell lysis redistributed chromium into a low-molecular-weight fraction spectroscopically similar to reported chromodulin.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/17263387.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "912905b2fefe0745017faae62124fe077d3944cde635ae1012ff76fc33094b35", "start_char": 0, "end_char": 1638, "text_sha256": "912905b2fefe0745017faae62124fe077d3944cde635ae1012ff76fc33094b35"}
- experimental_model
- X-ray absorption and EPR before and after cell fractionation
- exposure
- Cr(VI)-treated cells; comparisons with model Cr(III) complexes
- limitations
- The artifact evidence concerns chromium(VI)-exposed cells and the tested isolation procedures. It does not negate the activity measured when an isolated peptide preparation is added to an enzyme assay.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Human A549/HepG2, hamster V79 and mouse C2C12 cells
- plain_language
- Some apparent chromodulin-like material formed during sample preparation, raising doubts about its identity as a pre-existing cellular signal.
- primary_references
- [chromium-p17263387] X-ray absorption and EPR spectroscopic studies of the biotransformations of chromium(VI) in mammalian cells. Is chromodulin an artifact of isolation methods? (2007). https://pubmed.ncbi.nlm.nih.gov/17263387/ DOI: 10.1021/ja063792r
- tissue_or_cell_type
- Intact and lysed cell preparations
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 237–248
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · X-ray absorption and EPR before and after cell fractionation · source_derived_draft · unverified_draft
### chromium-chromodulin-isolation-artifact Most Cr(III) formed in Cr(VI)-treated cells was associated with high-molecular-mass ligands; cell lysis redistributed chromium into a low-molecular-weight fraction spectroscopically similar to reported chromodulin. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: Some apparent chromodulin-like material formed during sample preparation, raising doubts about its identity as a pre-existing cellular signal. organism: Human A549/HepG2, hamster V79 and mouse C2C12 cells tissue_or_cell_type: Intact and lysed cell preparations experimental_model: X-ray absorption and EPR before and after cell fractionation limitations: The artifact evidence concerns chromium(VI)-exposed cells and the tested isolation procedures. It does not negate the activity measured when an isolated peptide preparation is added to an enzyme assay. exposure: Cr(VI)-treated cells; comparisons with model Cr(III) complexes evidence_span: {"source_cache": "artifacts/chromium-research/17263387.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "912905b2fefe0745017faae62124fe077d3944cde635ae1012ff76fc33094b35", "start_char": 0, "end_char": 1638, "text_sha256": "912905b2fefe0745017faae62124fe077d3944cde635ae1012ff76fc33094b35"} [chromium-p17263387] X-ray absorption and EPR spectroscopic studies of the biotransformations of chromium(VI) in mammalian cells. Is chromodulin an artifact of isolation methods? (2007). https://pubmed.ncbi.nlm.nih.gov/17263387/ DOI: 10.1021/ja063792r
Complete structured claim and evidenceGlycated transferrin retained two chromium-binding equivalents but had altered spectroscopic behavior and greatly reduced chromium delivery in rats.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/chromium-research/27592288.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "541c9ba554cad6d899569dc16cdd68b1125542e2df006cb50db19f66d6e78d09", "start_char": 0, "end_char": 1460, "text_sha256": "541c9ba554cad6d899569dc16cdd68b1125542e2df006cb50db19f66d6e78d09"}
- experimental_model
- Transferrin incubation, metal binding and rat delivery experiments
- exposure
- Transferrin stored at 37°C with or without glucose before chromium binding and delivery assays
- limitations
- Protein storage itself altered binding. The glycated-protein result does not establish chromium deficiency in human diabetes or a treatment response.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Purified transferrin and rat in-vivo transport
- plain_language
- A carrier can still bind the metal yet distribute it less effectively.
- primary_references
- [chromium-p27592288] The effects of the glycation of transferrin on chromium binding and the transport and distribution of chromium in vivo. (2016). https://pubmed.ncbi.nlm.nih.gov/27592288/ DOI: 10.1016/j.jinorgbio.2016.08.008
- tissue_or_cell_type
- Carrier protein and systemic chromium distribution
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 471–482
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transferrin incubation, metal binding and rat delivery experiments · source_derived_draft · unverified_draft
### chromium-glycated-transferrin-delivery Glycated transferrin retained two chromium-binding equivalents but had altered spectroscopic behavior and greatly reduced chromium delivery in rats. Condition category: machinery_impairment nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: A carrier can still bind the metal yet distribute it less effectively. organism: Purified transferrin and rat in-vivo transport tissue_or_cell_type: Carrier protein and systemic chromium distribution experimental_model: Transferrin incubation, metal binding and rat delivery experiments limitations: Protein storage itself altered binding. The glycated-protein result does not establish chromium deficiency in human diabetes or a treatment response. exposure: Transferrin stored at 37°C with or without glucose before chromium binding and delivery assays evidence_span: {"source_cache": "artifacts/chromium-research/27592288.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "541c9ba554cad6d899569dc16cdd68b1125542e2df006cb50db19f66d6e78d09", "start_char": 0, "end_char": 1460, "text_sha256": "541c9ba554cad6d899569dc16cdd68b1125542e2df006cb50db19f66d6e78d09"} [chromium-p27592288] The effects of the glycation of transferrin on chromium binding and the transport and distribution of chromium in vivo. (2016). https://pubmed.ncbi.nlm.nih.gov/27592288/ DOI: 10.1016/j.jinorgbio.2016.08.008
Complete structured claim and evidenceThe study attributed about 5% of total chromium-DNA adducts to GSH-Cr-DNA crosslinks at 2 mM glutathione, with four- to fivefold higher crosslinking at 5 mM.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/18808157.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ed2c80b5da41d110da38bc0ed29d900d1d33f4180b64e13cb9b24ae7da5e1cdb", "start_char": 0, "end_char": 1724, "text_sha256": "ed2c80b5da41d110da38bc0ed29d900d1d33f4180b64e13cb9b24ae7da5e1cdb"}
- experimental_model
- Cell-free chromate reduction followed by plasmid replication in human fibroblasts
- exposure
- 2 versus 5 mM glutathione with Cr(VI)
- limitations
- Toxicology assay, not oral chromium exposure. Proposed crosslink identities depend on preparation and analytical methods; later work questions some pre-reacted ternary-adduct preparations.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Chemical system with human fibroblast mutagenicity readout
- plain_language
- The authors detected and assigned a glutathione-linked DNA lesion; the preparation and analytical assignment matter.
- primary_references
- [chromium-p18808157] Reduction with glutathione is a weakly mutagenic pathway in chromium(VI) metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/18808157/ DOI: 10.1021/tx800265g
- tissue_or_cell_type
- DNA reaction mixture and reporter plasmid
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 1173–1184
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-free chromate reduction followed by plasmid replication in human fibroblasts · source_derived_draft · unverified_draft
### chromium-gsh-chromate-adducts The study attributed about 5% of total chromium-DNA adducts to GSH-Cr-DNA crosslinks at 2 mM glutathione, with four- to fivefold higher crosslinking at 5 mM. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: The authors detected and assigned a glutathione-linked DNA lesion; the preparation and analytical assignment matter. organism: Chemical system with human fibroblast mutagenicity readout tissue_or_cell_type: DNA reaction mixture and reporter plasmid experimental_model: Cell-free chromate reduction followed by plasmid replication in human fibroblasts limitations: Toxicology assay, not oral chromium exposure. Proposed crosslink identities depend on preparation and analytical methods; later work questions some pre-reacted ternary-adduct preparations. exposure: 2 versus 5 mM glutathione with Cr(VI) evidence_span: {"source_cache": "artifacts/chromium-research/18808157.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ed2c80b5da41d110da38bc0ed29d900d1d33f4180b64e13cb9b24ae7da5e1cdb", "start_char": 0, "end_char": 1724, "text_sha256": "ed2c80b5da41d110da38bc0ed29d900d1d33f4180b64e13cb9b24ae7da5e1cdb"} [chromium-p18808157] Reduction with glutathione is a weakly mutagenic pathway in chromium(VI) metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/18808157/ DOI: 10.1021/tx800265g
Complete structured claim and evidenceOral coadministration of glutathione with labeled chromium did not significantly alter chromium retention in the rat study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/8605085.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "19976d36625bfcd29ba9739717e4b5ee7c2a641dc625a2bfed62947df7060889", "start_char": 0, "end_char": 1103, "text_sha256": "19976d36625bfcd29ba9739717e4b5ee7c2a641dc625a2bfed62947df7060889"}
- experimental_model
- Oral radiotracer retention and distribution experiments
- exposure
- Labeled oral chromium with dietary/metabolite coadministration
- limitations
- A negative retention result in this preparation does not exclude all chemical complexation or dose effects. Oral coadministration is not identical to a preformed chromium-nicotinate complex.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Rat
- plain_language
- Adding glutathione did not make the rats retain more chromium in this experiment.
- primary_references
- [chromium-p8605085] Dietary and metabolite effects on trivalent chromium retention and distribution in rats. (1995). https://pubmed.ncbi.nlm.nih.gov/8605085/ DOI: 10.1007/bf02789412
- tissue_or_cell_type
- Whole-body and tissue chromium
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 874–885
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Oral radiotracer retention and distribution experiments · source_derived_draft · unverified_draft
### chromium-gsh-retention-null Oral coadministration of glutathione with labeled chromium did not significantly alter chromium retention in the rat study. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: Adding glutathione did not make the rats retain more chromium in this experiment. organism: Rat tissue_or_cell_type: Whole-body and tissue chromium experimental_model: Oral radiotracer retention and distribution experiments limitations: A negative retention result in this preparation does not exclude all chemical complexation or dose effects. Oral coadministration is not identical to a preformed chromium-nicotinate complex. exposure: Labeled oral chromium with dietary/metabolite coadministration evidence_span: {"source_cache": "artifacts/chromium-research/8605085.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "19976d36625bfcd29ba9739717e4b5ee7c2a641dc625a2bfed62947df7060889", "start_char": 0, "end_char": 1103, "text_sha256": "19976d36625bfcd29ba9739717e4b5ee7c2a641dc625a2bfed62947df7060889"} [chromium-p8605085] Dietary and metabolite effects on trivalent chromium retention and distribution in rats. (1995). https://pubmed.ncbi.nlm.nih.gov/8605085/ DOI: 10.1007/bf02789412
Complete structured claim and evidenceInsulin stimulated transferrin-associated chromium transport from blood into rat tissues, with liver and kidneys prominent destinations.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/11472024.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba", "start_char": 0, "end_char": 1224, "text_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba"}
- experimental_model
- In-vivo chromium tracing with insulin stimulation
- exposure
- Administered chromium with transferrin transport and insulin comparisons
- limitations
- Rat tracer findings do not establish a required human insulin-signaling cofactor. Identification of urinary chromodulin was tentative in the indexed abstract.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Rat
- plain_language
- An insulin signal changed chromium distribution in this rat experiment.
- primary_references
- [chromium-p11472024] The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. (2001). https://pubmed.ncbi.nlm.nih.gov/11472024/ DOI: 10.1007/s007750100238
- tissue_or_cell_type
- Blood, tissues and urine
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 198–209
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · In-vivo chromium tracing with insulin stimulation · source_derived_draft · unverified_draft
### chromium-insulin-chromium-delivery Insulin stimulated transferrin-associated chromium transport from blood into rat tissues, with liver and kidneys prominent destinations. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: An insulin signal changed chromium distribution in this rat experiment. organism: Rat tissue_or_cell_type: Blood, tissues and urine experimental_model: In-vivo chromium tracing with insulin stimulation limitations: Rat tracer findings do not establish a required human insulin-signaling cofactor. Identification of urinary chromodulin was tentative in the indexed abstract. exposure: Administered chromium with transferrin transport and insulin comparisons evidence_span: {"source_cache": "artifacts/chromium-research/11472024.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba", "start_char": 0, "end_char": 1224, "text_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba"} [chromium-p11472024] The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. (2001). https://pubmed.ncbi.nlm.nih.gov/11472024/ DOI: 10.1007/s007750100238
Complete structured claim and evidenceInsulin-associated urinary chromium loss increased alongside a low-molecular-weight fraction interpreted as probable chromodulin in the rat study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/11472024.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba", "start_char": 0, "end_char": 1224, "text_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba"}
- experimental_model
- In-vivo chromium tracing with insulin stimulation
- exposure
- Administered chromium with transferrin transport and insulin comparisons
- limitations
- Rat tracer findings do not establish a required human insulin-signaling cofactor. Identification of urinary chromodulin was tentative in the indexed abstract.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Rat
- plain_language
- The experiment links insulin exposure to chromium loss, but the identity and physiological role of the urinary complex need qualification.
- primary_references
- [chromium-p11472024] The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. (2001). https://pubmed.ncbi.nlm.nih.gov/11472024/ DOI: 10.1007/s007750100238
- tissue_or_cell_type
- Blood, tissues and urine
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 211–222
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · In-vivo chromium tracing with insulin stimulation · source_derived_draft · unverified_draft
### chromium-insulin-urinary-chromium Insulin-associated urinary chromium loss increased alongside a low-molecular-weight fraction interpreted as probable chromodulin in the rat study. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: The experiment links insulin exposure to chromium loss, but the identity and physiological role of the urinary complex need qualification. organism: Rat tissue_or_cell_type: Blood, tissues and urine experimental_model: In-vivo chromium tracing with insulin stimulation limitations: Rat tracer findings do not establish a required human insulin-signaling cofactor. Identification of urinary chromodulin was tentative in the indexed abstract. exposure: Administered chromium with transferrin transport and insulin comparisons evidence_span: {"source_cache": "artifacts/chromium-research/11472024.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba", "start_char": 0, "end_char": 1224, "text_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba"} [chromium-p11472024] The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. (2001). https://pubmed.ncbi.nlm.nih.gov/11472024/ DOI: 10.1007/s007750100238
Complete structured claim and evidenceOral coadministration of nicotinic acid with labeled chromium did not significantly alter chromium retention in the rat study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/8605085.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "19976d36625bfcd29ba9739717e4b5ee7c2a641dc625a2bfed62947df7060889", "start_char": 0, "end_char": 1103, "text_sha256": "19976d36625bfcd29ba9739717e4b5ee7c2a641dc625a2bfed62947df7060889"}
- experimental_model
- Oral radiotracer retention and distribution experiments
- exposure
- Labeled oral chromium with dietary/metabolite coadministration
- limitations
- A negative retention result in this preparation does not exclude all chemical complexation or dose effects. Oral coadministration is not identical to a preformed chromium-nicotinate complex.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Rat
- plain_language
- Adding nicotinic acid did not make the rats retain more chromium in this experiment.
- primary_references
- [chromium-p8605085] Dietary and metabolite effects on trivalent chromium retention and distribution in rats. (1995). https://pubmed.ncbi.nlm.nih.gov/8605085/ DOI: 10.1007/bf02789412
- tissue_or_cell_type
- Whole-body and tissue chromium
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 861–872
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Oral radiotracer retention and distribution experiments · source_derived_draft · unverified_draft
### chromium-niacin-retention-null Oral coadministration of nicotinic acid with labeled chromium did not significantly alter chromium retention in the rat study. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: Adding nicotinic acid did not make the rats retain more chromium in this experiment. organism: Rat tissue_or_cell_type: Whole-body and tissue chromium experimental_model: Oral radiotracer retention and distribution experiments limitations: A negative retention result in this preparation does not exclude all chemical complexation or dose effects. Oral coadministration is not identical to a preformed chromium-nicotinate complex. exposure: Labeled oral chromium with dietary/metabolite coadministration evidence_span: {"source_cache": "artifacts/chromium-research/8605085.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "19976d36625bfcd29ba9739717e4b5ee7c2a641dc625a2bfed62947df7060889", "start_char": 0, "end_char": 1103, "text_sha256": "19976d36625bfcd29ba9739717e4b5ee7c2a641dc625a2bfed62947df7060889"} [chromium-p8605085] Dietary and metabolite effects on trivalent chromium retention and distribution in rats. (1995). https://pubmed.ncbi.nlm.nih.gov/8605085/ DOI: 10.1007/bf02789412
Complete structured claim and evidenceBinding of chromium-loaded transferrin to soluble transferrin receptor accelerated chromium release from both sites at acidic pH.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/31669693.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "bdb962ff7838d36dfbc2cd2df4eed4e07c81ebd824c6e95096c5d7069ec32835", "start_char": 0, "end_char": 1635, "text_sha256": "bdb962ff7838d36dfbc2cd2df4eed4e07c81ebd824c6e95096c5d7069ec32835"}
- experimental_model
- Purified human transferrin release kinetics and soluble receptor interaction
- exposure
- pH 4.5 and 5.5; weak/tight binding sites; biological chelators and soluble transferrin receptor
- limitations
- The study establishes release kinetics, not the entire in-vivo pathway. The molecular route from the endosomal lumen to cytosol remains unresolved.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Human proteins in vitro
- plain_language
- The receptor changed the carrier’s behavior and helped it release chromium in this assay.
- primary_references
- [chromium-p31669693] Release of trivalent chromium from serum transferrin is sufficiently rapid to be physiologically relevant. (2020). https://pubmed.ncbi.nlm.nih.gov/31669693/ DOI: 10.1016/j.jinorgbio.2019.110901
- tissue_or_cell_type
- Endosome-mimicking solution
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 172–183
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human transferrin release kinetics and soluble receptor interaction · source_derived_draft · unverified_draft
### chromium-receptor-accelerated-release Binding of chromium-loaded transferrin to soluble transferrin receptor accelerated chromium release from both sites at acidic pH. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: The receptor changed the carrier’s behavior and helped it release chromium in this assay. organism: Human proteins in vitro tissue_or_cell_type: Endosome-mimicking solution experimental_model: Purified human transferrin release kinetics and soluble receptor interaction limitations: The study establishes release kinetics, not the entire in-vivo pathway. The molecular route from the endosomal lumen to cytosol remains unresolved. exposure: pH 4.5 and 5.5; weak/tight binding sites; biological chelators and soluble transferrin receptor evidence_span: {"source_cache": "artifacts/chromium-research/31669693.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "bdb962ff7838d36dfbc2cd2df4eed4e07c81ebd824c6e95096c5d7069ec32835", "start_char": 0, "end_char": 1635, "text_sha256": "bdb962ff7838d36dfbc2cd2df4eed4e07c81ebd824c6e95096c5d7069ec32835"} [chromium-p31669693] Release of trivalent chromium from serum transferrin is sufficiently rapid to be physiologically relevant. (2020). https://pubmed.ncbi.nlm.nih.gov/31669693/ DOI: 10.1016/j.jinorgbio.2019.110901
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.